CNS Pharmaceuticals Files Q1 2025 10-Q
Ticker: CNSP · Form: 10-Q · Filed: May 15, 2025 · CIK: 1729427
| Field | Detail |
|---|---|
| Company | Cns Pharmaceuticals, Inc. (CNSP) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
**CNS Pharmaceuticals Q1 2025 10-Q filed. Financials and operations update.**
AI Summary
CNS Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial results and provided updates on its business operations. Specific financial figures for the quarter and comparative periods are detailed within the filing.
Why It Matters
This filing provides investors with the latest financial health and operational status of CNS Pharmaceuticals, Inc., crucial for understanding its current performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, CNS Pharmaceuticals faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-15 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- CNS Pharmaceuticals, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250515 (date) — Filing date
- HOUSTON (location) — Company headquarters city
- NV (location) — State of incorporation
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is for the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 15, 2025.
What is the company's name and Central Index Key (CIK)?
The company's name is CNS Pharmaceuticals, Inc., and its Central Index Key is 0001729427.
In which state was CNS Pharmaceuticals, Inc. incorporated?
CNS Pharmaceuticals, Inc. was incorporated in Nevada (NV).
What is the business address of CNS Pharmaceuticals, Inc.?
The business address is 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX 77027.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding CNS Pharmaceuticals, Inc. (CNSP).